UPLOAD Filing
CRESCENT BIOPHARMA, INC.
Date: Jan. 12, 2026 · CIK: 0001253689 · Accession: 0000000000-26-000353
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292600
Letter
January 12, 2026 Joshua Brumm Chief Executive Officer Crescent Biopharma, Inc. 300 Fifth Avenue Waltham, MA 02451 Re:Crescent Biopharma, Inc. Registration Statement on Form S-1 Filed January 7, 2026 File No. 333-292600 Dear Joshua Brumm: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Wesley C. Holmes, Esq.
Show Raw Text
January 12, 2026
Joshua Brumm
Chief Executive Officer
Crescent Biopharma, Inc.
300 Fifth Avenue
Waltham, MA 02451
Re:Crescent Biopharma, Inc.
Registration Statement on Form S-1
Filed January 7, 2026
File No. 333-292600
Dear Joshua Brumm:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Wesley C. Holmes, Esq.